Cargando…

A Novel Metabolism-Related Gene Signature for Predicting the Prognosis of HBV-Infected Hepatocellular Carcinoma

Metabolic reprogramming is one of the crucial hallmarks of cancer. Hepatocellular carcinoma (HCC) resulting from hepatitis B has various altered metabolic features. However, the impact of such alterations on the tumor microenvironment (TME) and immunotherapy efficacy is still unclear. Here, a progno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Zhenfu, Chen, Jingyun, Zhou, Yebin, Deng, Pan, Sun, Lu, Qi, Jun, Zhang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441393/ https://www.ncbi.nlm.nih.gov/pubmed/36072970 http://dx.doi.org/10.1155/2022/2391265

Ejemplares similares

A Novel Purine and Uric Metabolism Signature Predicting the Prognosis of Hepatocellular Carcinoma
por: Yang, Shengjie, et al.
Publicado: (2022)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)

A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Tian, Yilin, et al.
Publicado: (2022)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular Carcinoma
por: Zhou, Taicheng, et al.
Publicado: (2020)

A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma
por: Xu, Kequan, et al.
Publicado: (2022)

Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients
por: Zhu, Gui-Qi, et al.
Publicado: (2019)

HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative Resection
por: Liao, Rui, et al.
Publicado: (2018)

A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma
por: Li, Qinghe, et al.
Publicado: (2021)

A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma
por: Su, Lisa, et al.
Publicado: (2021)

Erratum: A metabolism- associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Frontiers Production Office,
Publicado: (2023)

The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
por: Tang, Bufu, et al.
Publicado: (2020)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma
por: He, Shujiao, et al.
Publicado: (2022)

A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses
por: Cai, Guangzhen, et al.
Publicado: (2022)

Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma
por: Li, Yu, et al.
Publicado: (2023)

A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma
por: Wang, Junli, et al.
Publicado: (2021)

SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2015)

A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma
por: Zhou, Weige, et al.
Publicado: (2020)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

A novel hypoxia-driven gene signature that can predict the prognosis of hepatocellular carcinoma
por: Zeng, Zhirui, et al.
Publicado: (2022)

A novel natural killer-related signature to effectively predict prognosis in hepatocellular carcinoma
por: Xi, Deyang, et al.
Publicado: (2023)

Identification Of Novel lncRNAs For Detection Of HBV-Associated Hepatocellular Carcinoma
por: Li, Yuwei, et al.
Publicado: (2019)

A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma
por: Yang, Ti, et al.
Publicado: (2023)

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma
por: Chen, Yongwei, et al.
Publicado: (2023)

The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Shuqiao, et al.
Publicado: (2022)

A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma
por: Dai, Xiaoyan, et al.
Publicado: (2021)

A novel tumor 4-driver gene signature for the prognosis of hepatocellular carcinoma
por: Guo, Houtian, et al.
Publicado: (2023)

Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma
por: Chang, Ming-Ling, et al.
Publicado: (2013)

A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma
por: Li, Yuyao, et al.
Publicado: (2022)

A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis
por: Lu, Mengxuan, et al.
Publicado: (2017)

Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection
por: Zhang, Xia, et al.
Publicado: (2016)

HBV DNA levels impact the prognosis of hepatocellular carcinoma patients with microvascular invasion
por: Li, Lian, et al.
Publicado: (2019)

ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2022)

Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
por: Wang, Yuxin, et al.
Publicado: (2023)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma
por: Liu, Rongqiang, et al.
Publicado: (2021)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Yan, Zongcai, et al.
Publicado: (2021)

A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma
por: Chen, Weigang, et al.
Publicado: (2022)

A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3pmh7jm61o9moqlpa417345c2b